deferoxamine has been researched along with Hepatitis, Viral, Human in 4 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Hepatitis, Viral, Human: INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hengeveld, P | 1 |
| Zuyderhoudt, FM | 1 |
| Katz, AJ | 1 |
| Prati, D | 1 |
| Triadou, P | 1 |
| Regnat-Lusinchi, A | 1 |
| Girot, R | 1 |
1 review available for deferoxamine and Hepatitis, Viral, Human
| Article | Year |
|---|---|
Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
Topics: Anemia, Hemolytic; beta-Thalassemia; Blood Group Incompatibility; Blood Transfusion; Cardiovascular | 2000 |
3 other studies available for deferoxamine and Hepatitis, Viral, Human
| Article | Year |
|---|---|
Iron mobilisation with chelating agents during acute viral hepatitis.
Topics: Alanine Transaminase; Bilirubin; Deferoxamine; Female; Hepatitis, Viral, Human; Humans; Iron; Liver; | 1982 |
Transfusion therapy: its role in the anemias.
Topics: Anemia; Blood Group Incompatibility; Blood Grouping and Crossmatching; Deferoxamine; Erythrocyte Tra | 1980 |
Use of the ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Transfusion; Combined Modality | 1989 |